tag Insulin Related Topics 
Fierce Pharma
NOVEMBER 18, 2022
Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim. fkansteiner. Fri, 11/18/2022 - 11:01.
STAT News
MARCH 10, 2023
Two recent studies aimed to quantify how much R&D costs impact a drug’s price, and how much effectiveness correlates with its price — factors that might, in theory, help justify a sizable price tag. But neither factor has much effect, the studies concluded. Continue to STAT+ to read the full story…
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT News
OCTOBER 6, 2022
million tag as cost effective for a Bluebird Bio drug called Zynteglo for the blood disorder beta thalassemia, Arbuckle said in an interview. Even a drug-price watchdog, the Institute for Clinical and Economic Review, deemed the $2.8
Rethinking Clinical Trials
AUGUST 22, 2022
Patients with diabetes or prediabetes were not excluded (except for those on insulin or sulfonylurea); pregnant patients were not excluded for the Metformin arm; the trial restricted participants to people who were overweight or obese to enrich the population for having a high risk of outcomes and for anti-inflammatory hypotheses around Metformin.
XTalks
NOVEMBER 3, 2022
Mounjaro was approved this summer as a Type 2 diabetes treatment and is the first diabetes drug with dual action, targeting two hormones involved in insulin production and appetite (GIP and GLP-1). In contrast, Novo’s diabetes drugs Ozempic and Rybelsus (both semaglutide) are just GLP-1 agonists.
Rethinking Clinical Trials
AUGUST 18, 2022
It leads to physiological changes, it leads to insulin resistance, changes in your immunology. When you live in an environment where you have been minoritized and are experiencing discrimination, it has an impact on your biology. There is plenty of data that shows that. The social circumstances affect health outcomes. New Ideas study.
pharmaphorum
JUNE 2, 2022
And of course, in many cases, these drugs have higher than average price tags compared to the wider market which is due to the limited – or in most cases – non-existent competition within a treatment area.”. Raising questions. Reaching a compromise. The broader movement across the industry is towards managing the financial cost of treatments.
Expert insights. Personalized for you.
97 
Let's personalize your content